Portal de Periódicos da CAPES

Congenital melanocytic nevi: Where are we now?

2012; Elsevier BV; Volume: 67; Issue: 4 Linguagem: Inglês

10.1016/j.jaad.2012.06.022

1097-6787

Omar A. Ibrahimi, Ali Alikhan, Daniel B. Eisen,

Cancer and Skin Lesions

Treatment of congenital melanocytic nevi (CMN) is generally undertaken for 2 reasons: (1) to reduce the chances of cutaneous malignant melanoma and (2) for cosmetic reasons. Over the past century, a large number of treatments for CMN have been described in the literature. These include excision, dermabrasion, curettage, chemical peels, radiation therapy, cryotherapy, electrosurgery, and lasers. Only low-level evidence supporting these approaches is available, and large randomized controlled trials have not been published. This article explores therapeutic controversies and makes recommendations based on the best available evidence.